Stock Events

Stock Events

ViroGates A/S 

€1.39
63
-€0.07-4.79% Monday 19:47

Statistics

Day High
1.39
Day Low
1.39
52W High
2.32
52W Low
0.84
Volume
-
Avg. Volume
-
Mkt Cap
10.75M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

17NovExpected
Q1 2021
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Q3 2022
-0.12
-0.1
-0.07
-0.05
Expected EPS
-0.06
Actual EPS
-0.05

Financials

-292.93%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
1.31MRevenue
-3.85MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow EP2.F. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Abbott Laboratories
ABT
Mkt Cap158.36B
Abbott Laboratories offers a broad range of diagnostics technologies, including biomarkers which compete with ViroGates' offerings.
Danaher
DHR
Mkt Cap125.45B
Danaher Corporation, through its subsidiaries, produces diagnostics solutions that overlap with the biomarker technology market of ViroGates.
Resmed
RMD
Mkt Cap32.03B
ResMed is involved in developing medical devices for respiratory disorders but also provides diagnostic tools that can compete with ViroGates.
Hologic
HOLX
Mkt Cap16.97B
Hologic specializes in diagnostics and medical imaging systems, competing in the broader diagnostics market where ViroGates operates.
Bio-Rad Laboratories
BIO
Mkt Cap7.77B
Bio-Rad Laboratories manufactures and supplies products and systems used for diagnostic testing, which competes with ViroGates' diagnostic solutions.
Bruker
BRKR
Mkt Cap5.56B
Bruker Corporation designs and manufactures scientific instruments, including diagnostic tools that can compete with ViroGates' products.

About

ViroGates A/S, an in vitro diagnostics company, develops and sells blood tests for measuring chronic inflammation for the healthcare sector. It offers suPARnostic TurbiLatex, a CE-IVD approved particle-enhanced turbidimetric immunoassay for quantitative measurement of suPAR in human plasma; suPARnostic AUTO Flex ELISA kit, a fully quantitative immunoassay designed for accurate and reliable measurement of soluble urokinase plasminogen activator receptor in human plasma; and suPARnostic Quick Triage, a test for rapid, quantitative measurement of suPAR levels. ViroGates A/S was founded in 2000 and is headquartered in Birkerød, Denmark.
Show more...
CEO
Country
Denmark
ISIN
DK0061030574
WKN
000A2JP7J

Listings

CO
DK
VIRO.CO
F
DE
EP2.F

0 Comments

Share your thoughts

FAQ

What is ViroGates A/S stock price today?▼
The current price of EP2.F is €1.39 EUR — it has decreased by -4.79% in the past 24 hours. Watch ViroGates A/S stock price performance more closely on the chart.
What is ViroGates A/S stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange ViroGates A/S stocks are traded under the ticker EP2.F.
Is ViroGates A/S stock price growing?▼
EP2.F stock has fallen by -4.79% compared to the previous week, the month change is a -6.08% fall, over the last year ViroGates A/S has showed a +64.3% increase.
What is ViroGates A/S market cap?▼
Today ViroGates A/S has the market capitalization of 10.75M
When is the next ViroGates A/S earnings date?▼
ViroGates A/S is going to release the next earnings report on May 07, 2026.
What is ViroGates A/S revenue for the last year?▼
ViroGates A/S revenue for the last year amounts to 1.31M EUR.
What is ViroGates A/S net income for the last year?▼
EP2.F net income for the last year is -3.85M EUR.
In which sector is ViroGates A/S located?▼
ViroGates A/S operates in the Other sector.
When did ViroGates A/S complete a stock split?▼
ViroGates A/S has not had any recent stock splits.